0001799828-23-000001.txt : 20230119 0001799828-23-000001.hdr.sgml : 20230119 20230119111828 ACCESSION NUMBER: 0001799828-23-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20230119 DATE AS OF CHANGE: 20230119 EFFECTIVENESS DATE: 20230119 FILER: COMPANY DATA: COMPANY CONFORMED NAME: EvolveImmune Therapeutics Holding Company, LLC CENTRAL INDEX KEY: 0001799828 IRS NUMBER: 843114936 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-471145 FILM NUMBER: 23536384 BUSINESS ADDRESS: STREET 1: C/O CANAAN PARTNERS STREET 2: 285 RIVERSIDE AVENUE, SUITE 250 CITY: WESTPORT STATE: CT ZIP: 06880 BUSINESS PHONE: 203-858-7389 MAIL ADDRESS: STREET 1: C/O CANAAN PARTNERS STREET 2: 285 RIVERSIDE AVENUE, SUITE 250 CITY: WESTPORT STATE: CT ZIP: 06880 D 1 primary_doc.xml X0708 D LIVE 0001799828 EvolveImmune Therapeutics Holding Company, LLC 23 Business Park Drive Branford CT CONNECTICUT 06405 203-858-7389 DELAWARE None None Limited Liability Company true 2019 Stephen Bloch 23 Business Park Drive Branford CT CONNECTICUT 06405 Executive Officer Director CEO and a Manager Alessandra Di Bacco c/o Takeda Ventures 300 Massachusetts Avenue Cambridge MA MASSACHUSETTS 02139 Director Manager Denis Patrick 9 Harvest Road New City NY NEW YORK 10956 Director Manager Ian Taylor 149 Country Way Madison CT CONNECTICUT 06443 Director Manager Derek Yoon 800 Boylston Street #2510 Boston MA MASSACHUSETTS 02199 Director Manager Biotechnology Decline to Disclose 06b false 2023-01-18 false true true true Convertible Promissory Notes false 0 26000000 10827780 15172220 false 8 0 0 0 No amounts other than ordinary course employment compensation is being paid to officers and managers. false EvolveImmune Therapeutics Holding Company, LLC Dr. Stephen Bloch Dr. Stephen Bloch Chief Executive Officer 2023-01-19